425: Strive CFO Cautions on Semler Scientific Merger Risks

Strive's CFO, Ben Pham, issued a cautionary statement regarding the proposed business combination with Semler Scientific, highlighting inherent risks and uncertainties.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are pursuing a proposed business combination.
• The communication, posted by Strive's CFO Ben Pham on September 22, 2025, serves as a cautionary statement regarding forward-looking statements related to the merger.
• The filing emphasizes that statements about the transaction's outlook, strategic and financial benefits, timing, and integration are subject to inherent risks and uncertainties.
• Investors are advised not to rely too heavily on forward-looking statements, as actual results could differ materially from anticipated outcomes.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued in connection with the transaction.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Sentiment

Score: 4

Explanation: The filing is a formal cautionary statement regarding a proposed merger, heavily emphasizing risks and uncertainties associated with forward-looking statements. While it mentions potential benefits, the primary tone is one of caution and risk disclosure, leading to a slightly negative or cautious sentiment.

Positives

• The proposed transaction is expected to yield strategic benefits and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are a potential outcome of the business combination.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close when expected or at all if closing conditions are not met or satisfied timely.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Dilution could occur due to Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may arise.
• Changes in Strive's or Semler Scientific's share price could occur before the closing of the transaction.

Future Outlook

The future outlook for the combined company, including strategic and financial benefits, the timing of the closing, and the ability to successfully integrate businesses, is subject to inherent risks and uncertainties. Strive and Semler Scientific believe their expectations are based on reasonable assumptions, but actual results may differ materially from projections.

Management Comments

• The communication was posted on X.com by Ben Pham, Chief Financial Officer of Strive, Inc., in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with Bitcoin and other digital assets, suggesting that the combined entity may be pursuing or considering strategies involving these assets, which aligns with a growing trend of corporate adoption of digital asset strategies, albeit with inherent volatility and regulatory uncertainties.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of both companies may see changes in share price before the closing of the transaction.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or experience changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Strive Inc., Semler Scientific Inc., Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Strategy, Digital Assets